We found that polymorphisms in TMPRSS2, ACE1, IFNAR2, and IFIH1 genes are associated with worse clinical outcomes (ICU admission) and increased mortality in patients with COVID-19, and this is influenced by sex and ethnicity. This evidence concerns the gene TMPRSS2 and COVID-19.